HRS-8829

Unknown / undisclosed

Mechanism not established

Automated registry profile: compiled from public clinical-trial and regulatory records; not yet individually analyst-verified.

—no market stage

Evidence outlook

Studies registered, no market-specific stage

Studies of this drug are registered, but none is matched to a market this site covers, so no stage is set and there is nothing to grade. The registry list shows each study.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 1 (1)
Other / comorbidity
NCT07083362 · Beijing Suncadia Pharmaceuticals Co., Ltd
2025-08-06 – 2026-01-12 · Acute Ischemia Stroke
What this study did

Competitive landscape

This drug's own stage for Acute Ischemic Stroke: Stage not on record. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
HRS-8829: this drugStage not on recordUndisclosed—not yet gradedNo reviewed efficacy summary in this indication
Ticagrelor (Brilinta)ApprovedSmall moleculeP2Y12 receptorReliable signal
NCT03354429: Composite of Subsequent Stroke or Death (From randomisation (day 1) to visit 3 (day 30-34)): TICAGRELOR 303 Participants | PLACEBO 362 Participants
Edaravone (TTYP01)Phase 3Small moleculeoxidative stressnot yet gradedNo reviewed efficacy summary in this indication
Rinvecalinase AlfaPhase 2/3Protein / enzyme therapeuticTissue kallikrein-1 (KLK1)not yet gradedNo reviewed efficacy summary in this indication
Apadamtase Alfa (Adzynma)Phase 2Protein / enzyme therapeuticADAMTS13not yet gradedNo reviewed efficacy summary in this indication
HRS-4029Phase 2Undisclosed—not yet gradedNo reviewed efficacy summary in this indication
HRS-7450Phase 2Undisclosed—not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

No upcoming readouts on record for this asset.